Abstract
This article aimed to review the current literature on the impact of continuous shedding of the COVID-19 virus in infected patients in relation to disease outcome variables and viral dynamics. Electronic databases PubMed, Google Scholar, and MedlinePlus were searched using relevant keywords, restricting the selection to thirty-two peer-reviewed articles and four gray literatures from the WHO websites. Findings from this study showed that several variables such as sex, age, immune status, treatments, and vaccines were found to affect the outcomes associated with the COVID-19 virus shedding. These findings highlight the need for further research using longitudinal whole-genome sequencing of the virus and its variants to increase the understanding.
Similar content being viewed by others
Availability of data and materials
Not applicable.
Code availability
Not applicable.
References
WHO (2021) Coronavirus disease (COVID-19): How is it transmitted? The World Health Organization. https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed 12 Nov 2022
WHO (2020) Coronavirus disease (COVID-19): virus evolution. www.who.int/news-room/q-a-detail/sars-cov-2-evolution. Accessed 12 Nov 2022
Achaiah NC, Subbarajasetty SB, Shetty RM (2020) R0 and Re of COVID-19: Can we predict when the pandemic outbreak will be contained? Indian J Crit Care Med 24:1125–1127. https://doi.org/10.5005/jp-jurnals-10071-23649
Huang SW, Wang SF (2021) SARS-CoV-2 entry related viral and host genetic variations: Implications on COVID-19 severity, immune escape, and infectivity. Int J Mol Sci 22:3060
Izurieta R, Gardellini T, Campos A, Parikh J (2022) Biological determinants of emergence of SARS-CoV-2 variants. IntechOpen, London. https://doi.org/10.5772/intechopen.104758
Lee JS, Yun KW, Jeong H, Kim B, Kim MJ, Park JH, Shin HS, Oh HS, Sung H, Song MG et al (2022) SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients. Virulence 13:1242–1251. https://doi.org/10.1080/21505594.2022.2101198
Letizia AG, Smith DR, Ge Y, Ramos I, Sealfon RSG, Goforth C, Gonzalez-Reiche AS, Vangeti S, Weir DL, Alshammary H et al (2021) Viable virus shedding during SARS-CoV-2 reinfection. Lancet Respir Med 9:e56–e57. https://doi.org/10.1016/S2213-2600(21)00219-8
Kim KW, Wang X, Adhikari A, Yeang M, Jenkins F, Naing Z, Walker GJ, Foster CSP, Stelzer-Braid S, Deveson I et al (2022) Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia. J Med Virol 94:4043–4046. https://doi.org/10.1002/jmv.27832
Falahi S, Kenarkoohi A (2020) COVID-19 reinfection: Prolonged shedding or true reinfection? New Microbes New Infect 38:100812. https://doi.org/10.1016/j.nmni.2020.100812
Long H, Zhao J, Zeng HL, Lu QB, Fang LQ, Wang Q, Wu QM, Liu W (2021) Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study. BMC Infect Dis. https://doi.org/10.1186/s12879-021-07002-w
Jariwal R, Raza N, Valdez M, Aboeed A, Garcia-Pacheco R (2021) Prolonged SARS-CoV2 viral shedding in an elderly patient. Cureus. https://doi.org/10.7759/cureus.15128
Sanyaolu A, Marinkovic A, Prakash S, Haider N, Williams M, Okorie C, Badaru O, Smith S (2022) SARS-CoV-2 Omicron variant (B.1.1.529): a concern with immune escape. World J Virol 11:137–143. https://doi.org/10.5501/wjv.v11.i3.137
WHO (2023) XBB.1.5 rapid risk assessment, 11 January 2023. The World Health Organization. https://www.who.int/docs/default-source/coronaviruse/11jan2023_xbb15_rapid_risk_assessment.pdf. Accessed 14 Jan 2023
Ravi V, Saxena S, Panda PS (2022) Basic virology of SARS-CoV 2. Indian J Med Microbiol 40:182–186. https://doi.org/10.1016/j.ijmmb.2022.02.005
Cevik M, Kuppalli K, Kindrachuk J, Peiris M (2020) Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. https://doi.org/10.1136/bmj.m3862
WHO (2020) Coronavirus disease (COVID-19) dashboard. The World Health Organization. https://covid19.who.int/info. Accessed 14 Nov 2022
Cao B, Jing X, Liu Y, Wen R, Wang C (2022) Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: Systematic review and meta-analysis. J Thorac Dis 14:1478–1487. https://doi.org/10.21037/jtd-22-345
Çalıca Utku A, Budak G, Karabay O, Güçlü E, Okan HD, Vatan A (2020) Main symptoms in patients presenting in the COVID-19 period. Scott Med J 65:127–132. https://doi.org/10.1177/0036933020949253
Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E (2020) A comprehensive review of COVID-19 characteristics. Biol Proced Online 22:19. https://doi.org/10.1186/s12575-020-00128-2
Paules CI, Marston HD, Fauci AS (2020) Coronavirus infections-more than just the common cold. JAMA 323:707–708. https://doi.org/10.1001/jama.2020.0757
Plebani M (2021) Persistent viral RNA shedding in COVID-19: caution, not fear. EBioMedicine 64:103234. https://doi.org/10.1016/j.ebiom
Loeffelholz MJ, Tang YW (2021) Detection of SARS-CoV-2 at the point of care. Bioanalysis 13:1213–1223. https://doi.org/10.4155/bio-2021-0078
Batra A, Clark JR, Kang AK, Ali S, Patel TR, Shlobin NA, Hoffman SC, Lim PH, Orban ZS, Visvabharathy L et al (2022) Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. Geroscience 44:1241–1254. https://doi.org/10.1007/s11357-022-00561
Owusu D, Pomeroy MA, Lewis NM, Wadhwa A, Yousaf AR, Whitaker B, Dietrich E, Hall AJ, Chu V, Thornburg N et al (2021) Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19. J Infect Dis 224:1362–1371. https://doi.org/10.1093/infdis/jiab107
Munker D, Osterman A, Stubbe H, Muenchhoff M, Veit T, Weinberger T, Barnikel M, Mumm JN, Milger K, Khatamzas E et al (2021) Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients. Eur Respir J 58:2002724
Lu Y, Li Y, Deng W, Liu M, He Y, Huang L, Lv M, Li J, Du H (2020) Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan. Pediatr Infect Dis J 39:e95–e99. https://doi.org/10.1097/INF.0000000000002729
Jacobsen H, Klein SL (2021) Sex differences in immunity to viral infections. Front Immunol 12:720952. https://doi.org/10.3389/fimmu.2021.720952
Torcia MG, Nencioni L, Clemente AM, Civitelli L, Celestino I, Limongi D, Fadigati G, Perissi E, Cozzolino F, Garaci E et al (2012) Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males. PLoS ONE 7:e39853. https://doi.org/10.1371/journal.pone.0039853
Taneja V (2018) Sex hormones determine immune response. Front Immunol 9:1931. https://doi.org/10.3389/fimmu.2018.01931
Zhang Y, Cen M, Hu M, Du L, Hu W, Kim JJ, Dai N (2021) Prevalence and persistent shedding of fecal SARS-CoV-2 RNA in patients with COVID-19 infection: a systematic review and meta-analysis. Clin Transl Gastroenterol 12:e00343. https://doi.org/10.14309/ctg.0000000000000343
Yan D, Liu XY, Zhu YN, Huang L, Dan BT, Zhang GJ, Gao YH (2020) Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection. Eur Respir J 56:2000799. https://doi.org/10.1183/13993003.00799-2020
Song KH, Kim DM, Lee H, Ham SY, Oh SM, Jeong H, Jung J, Kang CK, Park JY, Kang YM et al (2021) Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19. KJIM 36:11–14. https://doi.org/10.3904/kjim.2020.325
Harari S, Tahor M, Rutsinsky N, Meijer S, Miller D, Hening O, Halutz O, Levytskyi K, Ben-Ami R, Adler A et al (2022) Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat Med 28:1501–1508. https://doi.org/10.1038/s41591-022-01882-4
Lythgoe KA, Hall M, Ferretti L, de Cesare M, MacIntyre-Cockett G, Trebes A, Andersson M, Otecko N, Wise EL, Moore N, Lynch J (2021) SARS-CoV-2 within-host diversity and transmission. Science 372:eabg0821. https://doi.org/10.1126/Science.Abg0821
Kim KS, Iwanami S, Oda T, Fujita Y, Kuba K, Miyazaki T, Ejima K, Iwami S (2021) Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection. Life Sci Alliance 4:e202101049. https://doi.org/10.26508/lsa.202101049
Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, Park SY, Son HJ, Yu S, Park JW, Choo EJ (2020) Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA Intern Med 180:1447–1452. https://doi.org/10.1001/jamainternmed.2020.3862
Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Baniecki M, Hendrick VM, Damle B, Simón-Campos A et al (2022) Oral nirmatrelvir for high-risk, non-hospitalized adults with COVID-19. NEJM 386:1397–1408. https://doi.org/10.1056/NEJMoa2118542
Machkovech HM, Hahn AM, Wang JG, Grubaugh ND, Halfmann PJ, Johnson MC, Lemieux JE, O’Connor DH, Piantadosi A, Wei W, Friedrich TC (2024) Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(23)00815-0
Klivleyeva N, Lukmanova G, Glebova T, Shamenova M, Ongarbayeva N, Saktaganov N, Baimukhametova A, Basiseitt S, Ismagulova D, Kassymova G et al (2023) Spread of pathogens causing respiratory viral diseases before and during COVID-19 pandemic in Kazakhstan. Indian J Microbiol 63:129–138. https://doi.org/10.1007/s12088-023-01064-x
Ha KM (2023) Targeting the variants of COVID-19 via the unlimited approach. Indian J Microbiol 63:152–154. https://doi.org/10.1007/s12088-023-01057-w
Bajaj A, Purohit HJ (2020) Understanding SARS-CoV-2: genetic diversity, transmission, and cure in human. Indian J Microbiol 60:398–401. https://doi.org/10.1007/s12088-020-00869-4
Funding
None.
Author information
Authors and Affiliations
Contributions
Conceptualization, AS and RI. Original draft preparation, AM, SP, VB, KH, NH, AFA, ZH, KY. Revised and editing, AS, RI, SS, OB. Approved the version to be published, AS. Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved, AS.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Not applicable
Consent for publication
Not applicable
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sanyaolu, A., Marinkovic, A., Prakash, S. et al. Impact of Prolonged SARS-CoV-2 Viral Shedding on COVID-19 Disease Outcome and Viral Dynamics. Indian J Microbiol (2024). https://doi.org/10.1007/s12088-024-01238-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12088-024-01238-1